Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...

CIH names Rory Golod president of growth, targeting Compass platform adoption for 340,000 agents in 2026 and 2027.

A new solution from Basis puts campaign planning into the (figurative) hands of AI agents. But it's just a starting point.

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will report new clinical data from two ...

Basis ( the leading intelligent operating system for autonomous advertising, today announced an agentic AI solution that transforms campaign briefs into strategies and media plans that integrate ...